1- Perez JR, Kouroupis D, Li DJ, Best TM, Kaplan L, Correa D. Tissue engineering and cell-based therapies for fractures and bone defects. Frontiers in bioengineering and biotechnology. 2018; 6:105. Doi:10.3389/fbioe.2018.00105.
2- Fernandez de Grado G, Keller L, Idoux-Gillet Y, Wagner Q, Musset A-M, Benkirane-Jessel N. Bone substitutes: a review of their characteristics, clinical use, and perspectives for large bone defects management. Journal of tissue engineering. 2018; 9:241-9. Doi: 10.1177/2041731418776819.
3- Zeng J-H, Liu S-W, Xiong L, Qiu P, Ding L-H, Xiong SL. Scaffolds for the repair of bone defects in clinical studies: a systematic review. Journal of orthopaedic surgery and research. 2018; 13 (1):1-14. Doi: 10.1186/s13018-018-0724-2.
4- Claes L, Recknagel S, Ignatius A. Fracture healing under healthy and inflammatory conditions. Nature Reviews Rheumatology. 2012 ;8 (3):133-143. Doi: 10.1038/nrrheum.2012.1.
5- Batool F, Özçelik H, Stutz C, Gegout P-Y, Benkirane-Jessel N, Petit C. Modulation of immune-inflammatory responses through surface modifications of biomaterials to promote bone healing and regeneration. Journal of Tissue Engineering. 2021; 12:20-28. Doi: 10.1177/20417314211041428.
6- Khalil NY, Aldosari KF. Meloxicam. Profiles of drug substances, excipients and related methodology. 45: Elsevier. 2020.
7- Bekker A, Kloepping C, Collingwood S. Meloxicam in the management of post-operative pain: Narrative review. Journal of anaesthesiology, clinical pharmacology. 2018; 34 (4):450. Doi: 10.4103/joacp.JOACP-133-18.
8- Pawlukianiec C, Gryciuk ME, Mil KM, Żendzian-Piotrowska M, Zalewska A, Maciejczyk M. A new insight into meloxicam: assessment of antioxidant and anti-glycating activity in in vitro studies. Pharmaceuticals. 2020; 13 (9):240. Doi: 10.3390/ph13090240.
9- Ziegler A, Freeman C, Fogle C, Burke M, Davis J, Cook V. Multicentre, blinded, randomised clinical trial comparing the use of flunixin meglumine with firocoxib in horses with small intestinal strangulating obstruction. Equine veterinary journal. 2019; 51 (3):329-35. Doi: 10.1111/evj.13013.
10- Kleinhenz M, Van Engen N, Smith J, Gorden P, Ji J, Wang C. The impact of transdermal flunixin meglumine on biomarkers of pain in calves when administered at the time of surgical castration without local anesthesia. Livestock Science. 2018; 212:1-6.Doi: 10.1016/j.livsci.2018.03.016.
11- Adamička M, Adamičková A, Danišovič L, Gažová A, Kyselovič J. Pharmacological Approaches and Regeneration of Bone Defects with Dental Pulp Stem Cells. Stem Cells International. 2021. Doi: 10.1155/2021/4593322.
12- Almaawi A, Wang HT, Ciobanu O, Rowas SA, Rampersad S, Antoniou J. Effect of acetaminophen and nonsteroidal anti-inflammatory drugs on gene expression of mesenchymal stem cells. Tissue engineering Part A. 2013; 19 (7-8):1039-46.Doi: 10.1089/ten.tea.2012.0129.
13- Lim G, Lin G-H, Monje A, Chan H-L, Wang H-L. Wound healing complications following guided bone regeneration for ridge augmentation: a systematic review and meta-analysis. International Journal of Oral & Maxillofacial Implants. 2018; 33 (1). Doi: 10.11607/jomi.5581.
14- Aisa MC, Datti A, Orlacchio A, Di Renzo GC. COX inhibitors and bone: A safer impact on osteoblasts by NO-releasing NSAI.Doi: 10.1016/j.lfs.2018.07.011.
15- Mohammad RF, Human T, Mostafa H, Mohammad AZ. Wound healing activity of flaxseed Linum usitatissimum L. in rats. African Journal of Pharmacy and Pharmacology. 2011; 5 (21):2386-9. Doi: 10.5897/AJPP11.258.
16- Pourkarim R, Farahpour MR, Rezaei SA. Comparison effects of platelet-rich plasma on healing of infected and non-infected excision wounds by the modulation of the expression of inflammatory mediators: experimental research. European Journal of Trauma and Emergency Surgery. 2022; 1-9. Doi: 10.1007/s00068-022-01907-0.
17- Rajabloo Z, Farahpour MR, Saffarian P, Jafarirad S. Biofabrication of ZnO/Malachite nanocomposite and its coating with chitosan to heal infectious wounds. Scientific Reports. 2022; 12 (1):1-17. Doi: 10.1038/s41598-022-15768-5.
18- Kenkre J, Bassett J. The bone remodelling cycle. Annals of clinical biochemistry. 2018 ;55 (3):308-27. Doi: 10.1177/0004563218759371.
19- Copuroglu C, Calori GM, Giannoudis PV. Fracture non-union: who is at risk? Injury. 2013; 44 (11), 1379-82.
20- Spiro AS, Timo Beil F, Baranowsky A, Barvencik F, Schilling AF, Nguyen K. BMP‐7–induced ectopic bone formation and fracture healing is impaired by systemic NSAID application in C57BL/6‐mice. Journal of orthopaedic research. 2010; 28 (6), 785-791. Doi: 10.1002/jor.21044.
21- Welting T, Caron M, Emans P, Janssen M, Sanen K, Coolsen M. Inhibition of cyclooxygenase-2 impacts chondrocyte hypertrophic differentiation during endochondral ossification. Eur Cell Mater. 2011; 22 (420):36. Doi: 10.22203/eCM.v022a31.
22- Burd T, Hughes M, Anglen J. Heterotopic ossification prophylaxis with indomethacin increases the risk of long-bone nonunion. The Journal of bone and joint surgery British volume. 2003; 85 (5):700-5. Doi: 10.1302/0301-620X.85B5.13970.
23- Faot F, Deprez S, Vandamme K, Camargos GV, Pinto N, Wouters J, et al. The effect of L-PRF membranes on bone healing in rabbit tibiae bone defects: micro-CT and biomarker results. Scientific reports. 2017; 7 (1):1-10. Doi: 10.1038/srep46452.
24- Via LE, Lin PL, Ray SM, Carrillo J, Allen SS, Eum SY, Taylor K, Klein E. Manjunatha U, Gonzales J, Lee EG. Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates. Infection and immunity. 2008; 76 (6):2333-40. Doi: 10.1128/IAI.01515-07.
